PARTICIPATING COMPANIES

Companies participating at Biotech Showcase 2024

 
United States

20/20 GeneSystems, Inc.

 
 
United States

2Flo Ventures

 
Australia

360biolabs

 
 
Monaco

3B Future Health Ventures

 
 
United States

3CC

 
Canada

3DBioFibR Inc.

 
 
United States

3E Bioventures

 
 
United Kingdom

42 Therapeutics

 
 
United Kingdom

4BIO Capital

 
United States

4M Therapeutics, Inc

 
 
China

5Y Capital

 
 
United States

6 Dimensions Capital

 
United States

64x Bio

 
 
United States

7 Hills Pharma Inc.

 
 
United States

7G Bioventures

 
Japan

A -SEEDS Co., Ltd

 
 
Israel

AAA Family Office

 
United States

Aagami Inc

 
United States

AAIH

 
 
United States

AAVnerGene Inc.

 
 
United States

Abalone Bio

 
 
United States

AbBC Therapies

 
Canada

AbCellera

 
 
United States

Abingworth

 
South Korea

ABION Inc.

 
United States

Abiosciences, Inc

 
 
United States

Abyssinia Biologics, Inc.

 
 
Sweden

Accequa

 
United States

Access Vascular INC

 
United Kingdom

Accession Therapeutics Limited

 
United States

Acclaro Corporation

 
United Kingdom

Acclime

 
 
China

Accro Bio

 
 
United States

Accurius Therapeutics, Inc.

 
United States

Accutar Biotechnology Inc.

 
 
United States

Aceras Life Sciences

 
United States

Aclipse Therapeutics

 
 
United States

ACS BrightEdge

 
United States

Actinium Pharmaceuticals

 
 
United States

Actithera

 
United States

Acuamark Diagnostics, Inc.

 
 
United States

Acuris Partners

 
 
United States

Acutis Biosciences

 
Australia

Adalta Ltd

 
 
Switzerland

Addex Therapeutics

 
South Korea

ADEL

 
 
United States

Adepthera LLC

 
 
Australia

Adherium, Ltd

 
 
United States

AdimaBio Ventures

 
United States

Adiso Therapeutics

 
 
Canada

adMare BioInnovations

 
 
France

ADOCIA

 
Germany

Adrenomed AG

 
United States

ADRx, Inc.

 
United States

AdvaMed

 
United States

Adze Biotechnology, Inc

 
 
United States

Aegle Therapeutics

 
 
United States

Aeolian Biotech Corp.

 
France

AFFILOGIC

 
 
Japan

Aflac Ventures Japan .K.K

 
Denmark

AGC Biologics

 
 
United States

Agent Capital

 
 
United States

Agilent - Early Stage Partnerships

 
Belgium

Agio Capital

 
 
Netherlands

Aglaia Oncology Funds

 
Philippines

AGlobal Care, Inc.

 
 
United States

AIAC Family Office Group

 
Singapore

AIM Biotech

 
South Korea

AIMA co.Ltd.

 
South Korea

AIMED BIO INC.

 
United States

Aitia

 
 
United States

AIVITA Biomedical, Inc.

 
Japan

Ajinomoto Co., Inc.

 
 
United States

Ajinomoto Corporate Venture Capital

 
 
United States

Akadeum Life Sciences

 
 
United States

Akari Therapeutics

 
United States

Akttyva Therapeutics

 
Singapore

Albatroz Therapeutics

 
 
United Kingdom

Albion VC

 
France

Alderaan

 
 
United States

Alerce Investment Management

 
 
United States

Algen Biotechnologies, Inc.

 
 
United States

Alignment Ventures

 
 
United States

Aliris

 
United States

AliveCor

 
 
United States

Alix Ventures

 
Canada

Allarta Life Science Inc.

 
United States

Allele Capital Partners

 
Taiwan, China

Allgenesis Biotherapeutics Inc.

 
United States

Alliance for AI in Healthcare

 
United States

Alliance for Regenerative Medicine

 
United States

Allos

 
 
Canada

AllosteRx Capital

 
United States

Alloy Therapeutics

 
United States

Ally Bridge Group

 
 
United States

Alpha Bioventure LLC

 
 
Israel

Alpha Tau

 
 
United States

Alphyn Biologics, Inc

 
 
United States

Althea Group

 
United States

Altis Biosystems

 
 
Canada

Altius bioventures

 
United States

Altoida

 
United States

AltPep Corporation

 
China

Altruist Biologics, Inc.

 
United States

Alveolus Bio

 
United States

AmbioPharm

 
 
Canada

Ameretat Investment Ltd

 
Australia

Amplia Therapeutics

 
 
Canada

Amplitude Ventures

 
 
United States

Amplo Biotechnology

 
Belgium

AMYL Therapeutics

 
 
United States

AN Venture Partners

 
 
France

Andera

 
 
Sweden

Andra AP -fonden

 
 
United States

Andreessen Horowitz

 
Canada

ANGANY inc.

 
 
United States

Angel Investor

 
 
United States

Angelini Ventures

 
 
United States

Angels + Life.Sci Investors NJAngels.net

 
United States

Angiex Inc.

 
 
United States

Anixa Biosciences, Inc

 
France

ANTABIO SAS

 
Denmark

Antag Therapeutics

 
 
United States

Anthro Ventures

 
United Kingdom

Antiverse

 
 
United States

Anzu Partners

 
United States

Apellis

 
United Kingdom

APM Health Europe

 
 
United States

Apollo Health Ventures

 
 
United States

Apollomics Inc.

 
United States

Aponia Laboratories, Inc.

 
Israel

Aposense

 
 
South Korea

AprilBio Co., Ltd.

 
China

APS, Inc.

 
South Korea

Aptabio Therapeutics Inc.

 
United States

Aptevo Therapeutics

 
United States

Aqua Partners LLC

 
United States

Aqualung Therapeutics

 
United States

Aqualungtherapeutics.com

 
United States

ARaymond

 
South Korea

ARBORMED

 
United Kingdom

Arc Bio Communications

 
 
Canada

ARC Medical inc.

 
 
United States

Arc Ventures

 
 
United States

ARCH Venture Partners

 
 
Canada

Archangel Network of Funds

 
United States

Ardena US LLC

 
Germany

ARENSIA Exploratory Medicine GmbH

 
 
France

Argobio

 
Germany

Ariceum Therapeutics GmbH

 
 
United States

Arima Genomics

 
United States

ARIZ Precision Medicine

 
United States

Arizona Bioindustry Association (AZBio)

 
 
United States

Arkayli Biopharma Inc.

 
United States

Arog Pharmaceuticals, Inc.

 
Australia

Arovella Therapeutics

 
United States

ARPA -H

 
 
United States

Arpeggio Biosciences

 
United States

ArrePath, Inc.

 
United States

ARV Technologies

 
 
United States

Asabys Partners

 
 
United States

Asahi Kasei Pharma Corporation

 
 
Japan

Asahi Kasei Ventures

 
United States

Ascendia Pharmaceuticals, Inc.

 
 
United States

Ascendiant Capital

 
 
United States

Ascension Ventures

 
United States

ASDERA LLC

 
 
France

ASKLEPIOS ADVISORS

 
Singapore

Aslan Pharmaceuticals

 
 
United States

AssayQuant

 
United States

Astellas Pharma Inc.

 
 
United States

Astellas Rx + Business Accelerator LLC

 
 
United States

Astellas Venture Management LLC

 
 
United States

Astia

 
United States

Astrocyte Pharmaceuticals

 
United States

AsymBio

 
 
Belgium

atb therapeutics

 
 
United States

ATEL Ventures, Inc.

 
 
United States

ATEM Capital

 
 
United States

Athena Bioventures

 
 
Switzerland

AthenaDAO

 
 
United States

Atheneos Ventures LLC

 
 
South Korea

Atinum Investment

 
United States

ATOMIC AI

 
United States

Atomwise

 
Germany

Atriva Therapeutics GmbH

 
United States

Attivare Therapeutics

 
Israel

Aummune

 
Switzerland

Aurealis Therapeutics

 
 
United States

Aurion Biotech

 
 
Italy

AurorA Science s.r.l.

 
United States

AustinPx

 
United States

Author & Researcher

 
 
United States

Autobio Diagnostics (Invitro Diagnostics)

 
 
United States

AutoMedicus Corporation

 
 
United States

Auxilius Pharma

 
 
United States

AV8 Ventures

 
 
United States

Avalon Bioventures

 
 
United States

Avalor Therapeutics

 
United States

Avammune Therapeutics Inc.

 
United States

Avance Clinical

 
 
United States

Avant Bio

 
Australia

Avecho Biotechnology

 
 
United States

Aviceda Therapeutics

 
United States

Avidity Bioscience

 
United States

Avstera Therapeutics Corp.

 
 
Switzerland

Awen GmbH

 
 
United States

AXA IM

 
 
Singapore

Axcynsis Therapeutics

 
 
United States

Axial Therapeutics

 
 
Japan

Axil Capital

 
France

AXOLTIS PHARMA

 
 
United States

Azitra, Inc.

 
 
United States

Azome Therapeutics Inc

 
United States

B7 Therapeutics

 
United States

Bachem

 
 
United Kingdom

Backed VC

 
Belgium

Backstage communication

 
United States

BairesDev

 
Thailand

Baiya Phytopharm Co., Ltd.

 
 
United States

Band of Angels

 
Israel

Barcode Nanotech

 
United Kingdom

Barrington James

 
United States

Battelle Memorial Institute

 
 
United States

Bay Area life sciences angels. UC Davis health

 
 
United States

BayMed Venture Partners, LLC

 
China

Beijing CorreGene Biotechnology Co., Ltd

 
United States

Beiwe Pharma, LLC

 
 
United States

beldon global

 
 
United States

Ben Franklin Technology Partners of Southeastern PA

 
 
United States

Benchmark Company

 
Greece

BENOSTAN SA

 
 
United States

Bering Capital

 
 
United States

Berkeley Angel Network

 
 
United States

Betawave Ventures

 
 
United States

Bexion Pharmaceuticals

 
Australia

Beyond Drug Development

 
 
Japan

Beyond Next Ventures Inc.

 
South Korea

BeyondBio Inc

 
United States

Big4Bio

 
United Kingdom

Bilal Bham International

 
United States

Bilayer Therapeutics, Inc.

 
 
South Korea

Bilix, Co., LTD

 
United States

Bill and Melinda Gates Foundation

 
United States

BIO

 
South Korea

Bio Design Lab

 
 
Canada

Bio Ideations

 
United States

BioCentury

 
 
United States

Bioceptive Holdings - Family Office

 
Australia

BioCina

 
United States

Biocom California

 
China

Biocytogen Pharmaceuticals (Beijing) Co. Ltd

 
United States

BioDirectors, LLC

 
United States

BioDuro -Sundia

 
 
Netherlands

BioGeneration Ventures

 
 
United States

Biograph Venture

 
 
United States

BioHealth Innovation, Inc.

 
 
United States

Bioidea Group

 
United States

BIOIO

 
 
United States

Biolexis Therapeutics

 
 
United States

BioMap

 
 
Australia

BiomeBank

 
 
Slovakia

Biomedica EE, s.r.o.

 
United States

Biomedica Group

 
 
United States

BiomEdit, LLC

 
Israel

Biomica Ltd.

 
 
Canada

BioMimir Inc.

 
 
United States

Biomissile Pharmaceuticals

 
United States

BioNJ

 
 
Australia

Bionomics Ltd

 
United States

BioOncology Consulting, LLC

 
 
United States

BioPacific Investors, Inc.

 
United Kingdom

BioPartner UK

 
United States

BioPharm Strategy

 
United States

BioPharma Dive

 
United States

BioProcess international (Part of Informa Connect)

 
 
Belgium

Bioqube Ventures

 
 
South Korea

BIORCHESTRA Co., Ltd.

 
 
South Korea

Biorevert Inc.

 
 
United States

BioRock Ventures

 
 
United States

Bios Partners

 
 
Australia

Bioscience Equity Partners Inc

 
United States

BioscienceLA

 
United States

BioSpace

 
 
United States

BiosPartners

 
 
United States

BioStrategies LC

 
United States

BioStrategy Partners Inc

 
Canada

BIOTECanada

 
United States

Biotech Metropolitan Women

 
 
Netherlands

Biotech Mountains BV

 
United States

Biotech Networks

 
United States

BiotechExec

 
United States

Biotechgate

 
China

Biotheus

 
United States

BioTools Innovator

 
Germany

biotx.ai GmbH

 
Canada

BIOVECTRA

 
United States

Biovian

 
United States

Bioviida Venture Studio

 
 
Luxembourg

Biovision Ventures

 
United States

BioWorld

 
 
Belgium

Bioxodes SA

 
 
United States

Bison Ventures

 
 
Switzerland

BlackRock

 
Brazil

BLANVER FARMOQUIMICA E FARMACEUTICA SA

 
 
South Korea

Bluepoint Partners

 
 
China

Blueray Biopharma

 
 
United States

Bluestar Investment Managers

 
 
United States

BlueYard Capital

 
South Korea

BNC Korea Co., Ltd.

 
 
United States

Body Vision Medical

 
 
China

BOHE Angel Fund

 
Canada

Bold Therapeutics Inc.

 
 
United States

Bonaventure Equity, LLC

 
 
United States

Bond Biosciences, Inc.

 
United States

Boom Capital

 
South Korea

Boryung Co., Ltd.

 
 
United States

Boston Harbor Angels

 
 
France

Bpifrance

 
 
Netherlands

Brabant Development Agency (BOM)

 
 
United States

Brace Pharma

 
United States

Brain TX

 
United States

brain4care

 
United States

BRAINBox Solutions, inc

 
 
United States

Brainify.AI

 
 
Australia

Brandon Capital Partners

 
United States

Breakout Ventures

 
 
Germany

Breakpoint Therapeutics GmbH

 
 
Switzerland

BRESLIN AG

 
United States

BriaCell Therapeutics Corp.

 
United States

Bridge

 
 
United States

Bridgewest Group

 
United States

Bright Global Health

 
United States

Bright Minds Biosciences

 
Canada

British Columbia Trade and Invest

 
United States

British Consulate

 
 
United States

Broadview Ventures

 
 
United States

Brookline Capital Markets

 
 
United Kingdom

Brookstreet Equity

 
 
France

Brothers and Partners Europe

 
China

Buchang(Beijing)Pharmaceutical R&D Co.,Ltd

 
 
United States

Builders VC

 
United States

Buto Corporation

 
 
United States

Button Capital

 
 
United States

BVCF

 
 
United States

C.M. Capital

 
United States

C14 COnsulting Group

 
Canada

C3i Center Inc

 
Japan

C4U Corporation

 
 
United States

Cadrenal Therapeutics

 
 
Norway

Caedo Oncology

 
 
Canada

Caledon Bioscience Inc.

 
United States

California Biomanufacturing Center

 
United States

California Israel Chamber of Commerce

 
United Kingdom

Camallergy

 
 
United States

Camber Road Partners

 
 
United States

Cambrian Capital Partners, LLC

 
 
United States

Camford Capital

 
 
United Kingdom

Cancer Research Horizons

 
United States

Cancer Research Institute

 
 
United States

Cancerfree biotech

 
United States

Cantex Pharmaceuticals

 
 
United States

Cantilever Investors

 
Canada

Canurta Inc

 
 
Canada

Capital Angel Network

 
 
United States

Capital One Securities

 
France

CARANX MEDICAL

 
 
Germany

CARELA HOLDING

 
Australia

Carina Biotech

 
United States

Catalyst Clinical Research

 
 
Israel

Catalyst Investments - Medical Technologies

 
 
Israel

Catalyst Investments -Medical Aesthetics and Digital health

 
 
United States

Catalytic Impact Foundation

 
United States

Catalytic Life Sciences, Inc

 
 
United States

Cathay Capital

 
 
United States

CAV Angels

 
 
Japan

CBC Group

 
 
United States

CBCC Family Office

 
 
Canada

CCRM Enterprises

 
 
China

CD Capital

 
 
Belgium

Cellaion

 
South Korea

Cellartgen Inc.

 
United States

Celldom, Inc.

 
United States

Cellectar Biosciences Inc

 
United States

CELLF - BIO

 
United States

CellFE Inc.

 
United States

Cellino

 
Netherlands

CellResearch Therapeutics

 
United States

CellVax Therapeutics, Inc.

 
United States

CellXLife

 
 
Australia

Celosia Therapeutics Pty Ltd

 
 
Canada

Centre for Aging + Brain Health Innovation

 
Norway

CEPI

 
United States

Ceria Therapeutics, Inc.

 
United States

Certara

 
United States

CFOsquared, Inc.

 
United States

CG Life

 
South Korea

CHA BIO GROUP

 
 
China

ChainGen Biopharma Ltd

 
China

Changchun GeneScience Pharmaceutical Co.,Ltd.

 
 
Puerto Rico

Chardan

 
United States

Charles River

 
Switzerland

CheckOrphan

 
United States

Chemical & Engineering News

 
 
United States

Chemical Angel Network

 
 
China

Chengdu Guanghua Wutong Equity Investment Fund Management Co.,Ltd

 
 
United States

Chiesi Ventures

 
Australia

Children's Medical Research Institute

 
 
Canada

Chimeric Therapeutics Limited

 
United States

Chimeron Bio

 
United States

China Daily USA

 
 
United States

Chrysalis BioTherapeutics, Inc.

 
Ireland

Chrysea Limited

 
France

Cilcare

 
United States

Cincinnati Children's Hospital

 
Norway

Circio

 
United States

Citeline

 
China

Citeline Pharma intelligence

 
 
United States

Civilization Ventures

 
United States

Clarivate plc

 
 
United States

Class Bravo Ventures

 
United States

Clayton Biotechnologies, Inc.

 
United States

Clear Gene, Inc.

 
 
United States

Cleveland Clinic Ventures

 
United States

Clinical Conversations

 
United States

clock.bio

 
 
United States

Cloudstone Venture Fund, L.P.

 
Japan

CLOVERNA, Inc.

 
Australia

CMAX Clinical Research

 
 
United States

Coagulant Therapeutics

 
 
United States

Coast Bioventures LLC

 
Canada

Cobionix

 
 
United States

Cobro Ventures

 
 
United States

Codon Capital

 
 
China

Codone Biotech

 
 
United States

Coeurative, Inc.

 
 
United States

Cognigenics, Inc.

 
United States

Cognito Therapeutics

 
France

Cohesion Bureau

 
 
United States

Coho VC

 
 
United States

Columbia Tech Ventures

 
 
United States

Combined Therapeutics

 
 
South Korea

Company K Partners

 
United Kingdom

COMPASS Pathfinder Ltd

 
United States

Concarlo Therapeutics

 
United Kingdom

Concept Life Sciences Limited

 
United States

Consulate General of Canada

 
United States

Content Carnivores, LLC

 
Canada

Continuum Health Ventures

 
United States

Convalesce Inc.

 
 
Switzerland

Convergence Partners

 
 
United States

Convergent Ventures

 
Belgium

convEyXO

 
United States

Corden Pharma

 
 
Japan

Corundum System Biology

 
United States

Covington & Burling, LLP

 
United States

CPC SCIENTIFIC, INC.

 
 
United States

CR Ventures

 
 
United Kingdom

Creasallis

 
United States

Createrna Science & Technology

 
United States

CRISPR QC, Inc.

 
 
France

CROSSJECT

 
United States

Crosswave Management

 
United States

Crovelis

 
United States

Crowe LLP

 
United States

Cryoport Systems

 
Canada

CryoStasis Inc.

 
 
United States

CT Innovations

 
United States

Cullgen Inc.

 
 
United States

Cura Capital

 
 
United States

Cura Therapeutics

 
South Korea

Curacle Co., Ltd.

 
 
United States

Curative Ventures

 
United States

Cure.

 
United States

CureLab Oncology

 
United States

CureMeta

 
Switzerland

Cureteq AG

 
United States

Curi Bio

 
United States

Curia

 
 
Netherlands

Curie Capital

 
 
United States

Curie.Bio

 
 
United Kingdom

Curve Therapeutics

 
Canada

Customized Homecare

 
United States

Cuttlefish Communications

 
 
United States

Cyclacel Pharmaceuticals, Inc.

 
 
United States

Cystic Fibrosis Foundation

 
Japan

CyTIX Inc.

 
 
United States

CytoAgents, Inc

 
United States

Cytonus Therapeutics Inc.

 
United States

Cytovance Biologics, Inc

 
 
South Korea

Daejoong Life Science

 
South Korea

Daewoong Pharmaceutical

 
 
United States

Data Expanse Ventures

 
 
United States

David Fox Syndicate

 
United States

DavosPharma

 
 
South Korea

DAYLI partners

 
 
China

DCP Capital

 
Australia

De Motu Cordis

 
 
United Kingdom

DeBere

 
 
Switzerland

Debiopharm Innovation Fund SA

 
 
United States

Decheng Capital

 
United States

DeckTherapeutics, Inc.

 
Canada

Deep Genomics

 
United States

DeepCure

 
 
United Kingdom

DeepMirror

 
 
United States

Deerfield

 
United States

Defand Therapeutics

 
 
United States

Defined Bioscience Inc

 
 
United States

DEFTA Partners

 
United States

DEL BioPharma LLC

 
 
China

Delian Capital

 
 
United Kingdom

Delin Ventures

 
United States

Delpor, Inc.

 
 
United States

Dementia Discovery Fund/ SV Health Investors

 
United States

Department of Health and Human Services, Administration for Strategic Preparedness and Response, Biomedical Advanced Research and Development Authority

 
United States

Department of Veterans Affairs

 
United States

Dermaliq Therapeutics Inc.

 
Canada

Desire Ventures Inc.

 
United Kingdom

Destiny Pharma plc

 
 
United States

Device of Tomorrow Capital llc

 
 
United States

DFA Advisors

 
 
United States

DFB Pharmaceuticals

 
 
Japan

DG Daiwa Ventures

 
South Korea

DGIST

 
 
Taiwan, China

Diamond Biofund

 
 
United States

Diamond Edge Ventures

 
United States

Diapin Therapeutics, LLC

 
Sweden

Dicot AB

 
 
United States

DigiLife Funds

 
United States

Digital Medicine Society, Inc

 
United States

Digital.Health / Continuum Health Ventures / NextMed Health

 
 
United States

Dionysus Digital Health, Inc

 
 
United States

Diorasis Therapeutics

 
 
United States

DiscGenics

 
 
United Kingdom

Discovery Park Ventures

 
United States

DJK BioConsult

 
United States

DNA Analytics

 
 
United States

Dolby Family Ventures

 
South Korea

Dong -A ST

 
 
United States

Dorset Capital LLC

 
 
United States

Double u fund/ Jetkar

 
United States

Drug Discovery News

 
 
China

DSciLab Co., Ltd.

 
South Korea

DT&CRO

 
South Korea

DX & VX

 
 
United Kingdom

Dxcover

 
Japan

Dydo Pharma, Inc.

 
Germany

Dynamic Biosensors GmbH

 
United States

Dynamica Biologics Consulting

 
 
Canada

e -Fund

 
Japan

e -Projection K.K.

 
Japan

EA Pharma Co., Ltd.

 
United States

EarlyDiagnostics, Inc

 
India

Eccentric Clinical Research Pvt. Ltd.

 
United States

ECI Therapeutics

 
South Korea

Economist of EdailyM

 
 
United States

Ecphora Capital Management Company, LLC

 
United States

EdgeOne Medical Inc.

 
Japan

EditForce, Inc.

 
 
United States

EDventure Holdings

 
 
Puerto Rico

EGB, Ventures

 
 
Israel

Eight Bridges

 
 
Japan

Eight Roads Ventures

 
China

Eisai China Inc

 
 
Japan

Eisai Co., Ltd.

 
 
United States

Eisai Innovation Inc

 
United Kingdom

Elasmogen Ltd

 
United States

Eledon Pharmaceuticals

 
 
United States

Elenae Therapeutics, Inc.

 
Germany

eleva GmbH

 
 
United States

Elevate Ventures

 
France

Eligo Bioscience

 
United States

Eliquent

 
Japan

Elix, Inc.

 
United States

Elixirgen Therapeutics

 
United Kingdom

Ellipses Pharma Ltd

 
United States

Elsie Bio

 
 
United States

Embold Therapeutics

 
 
United States

Emcif Fund

 
Germany

EMD Serono

 
 
United States

Emerald Bioventures, LLC

 
 
United States

Emily Welsch

 
United States

Encellin

 
United States

Endotarget, Inc.

 
 
Australia

Endpoints Capital Pty Limited

 
United States

Endpoints News

 
 
United States

Endure Biotherapeutics, Inc.

 
United States

Engadget

 
Switzerland

Engimmune Therapeutics AG

 
 
United States

Engine Ventures

 
Canada

Enhanced Medical Nutrition (EMN)

 
United Kingdom

Enigma Therapeutics Ltd

 
United States

Enosi Therapeutics

 
 
United States

Enquyst Technologies Inc

 
United States

Entac Medical Inc

 
United States

Entegris Corporate Venture Capital

 
United States

ENTENTE Network of Companies

 
Singapore

Enterprise Singapore

 
United States

EntityRisk, Inc.

 
United States

Entvin, Inc.

 
 
United States

Entwine Bio

 
United States

Enveric Biosciences

 
United States

Envisagenics

 
India

Enzene Biosciences Inc.

 
 
United States

Eos BioInnovation

 
Belgium

Epics Therapeutics

 
 
United Kingdom

Epidarex Capital

 
 
United States

Epion Therapeuitcs, Inc.

 
 
United States

EpiVario Inc

 
United States

Ergomed

 
 
United States

Eric Anschutz

 
 
United States

Ermaris Bio, PBC

 
Belgium

ESOBIOTEC

 
 
United Kingdom

Esperante Ventures BV

 
 
United States

Espervita Therapeutics

 
United Kingdom

Etcembly Ltd

 
 
Germany

Ethris GmbH

 
South Korea

eToday

 
South Korea

EuBiologics Co., Ltd.

 
 
United States

Eucalyptus Bio

 
United States

Euclidean Life Science Advisors, LLC

 
 
United States

Eugit Tx

 
 
United States

EuPOP Life Sciences

 
Canada

Eurofins CDMO Alphora Inc

 
United Kingdom

European Pharmaceutical Review

 
 
United States

EV Therapeutics

 
United States

Evaluate

 
 
United Kingdom

Evariste

 
United States

Evecxia Therapeutics

 
United Kingdom

Evgen Pharma plc

 
United States

Evidation

 
 
United Kingdom

Evolutia Venture Partners

 
 
Canada

ExCellThera Inc.

 
United States

ExcepGen

 
United States

Excision BioTherapeutics

 
Spain

Exeltis

 
United States

Exemplar Capital, LLC

 
 
United Kingdom

Exonate Ltd

 
 
United States

EXXclaim Capital

 
Canada

Eyam Vaccines and Immunotherapeutics

 
 
United States

FAMILY TRUST

 
 
Singapore

Farquhar VC

 
 
United States

Fast Track Initiative, Inc.

 
United States

Fauna Bio

 
Canada

Feldan Therapeutics

 
Japan

FELIQS

 
 
Japan

Fermelanta

 
Denmark

Ferring Pharmaceuticals A/S

 
Germany

FGK Clinical Research GmbH

 
 
United States

FibroBiologics

 
 
Canada

Fiddlehead Ventures

 
United States

Fierce Biotech

 
United States

Fierce Pharma

 
 
United States

Finney Capital

 
United States

First Ascent Biomedical Inc

 
United States

FirstWord Pharma

 
 
Australia

FivepHusion

 
 
United States

Flagship Pioneering

 
Belgium

flanders.bio

 
 
Sweden

Flerie Invest

 
 
United States

FloraWorks USA Ltd.

 
 
United States

Flu Lab

 
United States

FluidForm Bio

 
 
United States

Focal Medical

 
United States

Foley Hoag

 
United States

Forbes

 
 
Netherlands

Forbion

 
United States

Forcyte Biotechnologies, Inc

 
United States

Foresite Advisors

 
United States

Formation Bio

 
United States

Fortrea

 
 
South Korea

Fortuga Bio

 
 
United States

Fortunatus Capital

 
 
China

Fortune VC

 
 
South Korea

Forward Equity Partners

 
 
Switzerland

FoRx Therapeutics AG

 
 
United States

FOS Capital Partners

 
Switzerland

Fosun Pharmaceutical AG

 
 
United States

FoundersX Ventures

 
 
Ireland

Fountain Healthcare Partners

 
 
United States

FoxHill Asset Management

 
Germany

Fraunhofer ITEM

 
 
United States

Freedom Capital

 
Ireland

Freelance

 
United States

Freelancer

 
United States

FreeMind Group

 
 
United States

FreeMind Investments

 
United States

FREENOME

 
 
Netherlands

Freya Pharma Solutions

 
United States

Fujifilm Irvine Scientific

 
United States

Fuse Oncology, Inc.

 
Canada

Fusion Genomics Corporation

 
Israel

FutuRx

 
United States

Fzata, Inc.

 
United States

Gain Therapeutics, Inc.

 
Belgium

Galapagos

 
United States

Gameto

 
 
United States

Gamma Biosciences

 
United States

Gardenia Media

 
United States

Gateway Biotechnology

 
South Korea

GC Biopharma

 
 
United States

GCF Family Office

 
 
United States

GelSana

 
 
United States

GEM

 
 
Japan

Gemseki Ventures LP - Japan

 
 
Japan

Gemseki Ventures LP - US

 
 
United States

Genascence

 
 
Canada

Gene Bio Medical

 
 
United States

GeneLancet Biosciences, Inc.

 
United States

GeneOnline US INC

 
 
Canada

Genesys Capital

 
United States

Genetic Engineering & Biotechnology News

 
United States

GeneVentiv Therapeutics, Inc.

 
 
United States

Genialis, Inc

 
United States

GeniPhys

 
 
United States

Genoa VC

 
 
Canada

Genome BC Industry Innovation Fund

 
South Korea

Genome Opinion

 
United States

Genopore Ltd.

 
 
China

Gensciences Biopharma

 
United States

GenScript USA Inc

 
United States

George Clinical

 
 
United States

GeoVax Labs, Inc.

 
 
United States

GEX Ventures Inc.

 
 
Hong Kong, S.A.R.

GF Investment (Hong Kong) Limited

 
 
United States

GHO Capital

 
South Korea

GI Innovation

 
United States

Gilboa Therapeutics

 
United States

Gilead Sciences

 
United States

Ginkgo Bioworks

 
Canada

GL CHEMTEC INTERNATIONAL

 
 
United States

Global Alpha Ventures

 
 
United States

Global Asset Capital, LLC

 
 
United States

Global BioAccess Fund

 
 
United Kingdom

Global Brain

 
 
United States

Global Health Investment Corporation

 
Australia

Global Pharma Solutions (GPS)

 
United States

Global Webcasting Group

 
United States

GlobalData

 
United States

Globant

 
Netherlands

Glycostem Therapeutics B.V.

 
United States

Glyscend Therapeutics

 
 
France

GO CAPITAL

 
United States

GO Therapeutics

 
 
Switzerland

GOGOL ASSOCIATES

 
 
United States

Golden Seeds

 
 
United States

Good Health Capital

 
 
Canada

GoodCap Pharmaceuticals

 
Japan

Goryo chemical Inc.

 
 
United States

GPG Ventures

 
Germany

GQ Bio Therapeutics

 
 
South Korea

gradiant

 
 
United States

GrapheneDx

 
United States

Gravitas Medical

 
 
United States

GreenJay Therapeutics, Inc.

 
 
Canada

GreenSky Ventures

 
 
Spain

Grifols SA

 
 
United States

grikitis group

 
 
United States

GSR Ventures

 
 
China

Guangzhou KingMed Diagnostics Group

 
 
United Kingdom

H Tree Capital

 
 
Taiwan, China

H&D Asset Management Co., Ltd.

 
United States

H. Lee Moffitt Cancer Center & Research Institute

 
 
United States

H.C. Wainwright & Co.

 
 
Australia

H3Healthcare

 
 
United States

H7 BioCapital

 
 
United States

Halia Therapeutics

 
Taiwan, China

HanchorBio Inc.

 
China

Hangzhou Highfield Biopharmaceuticals

 
 
China

Hankang Capital

 
South Korea

Hanmi Pharmaceuticals

 
 
United States

Hannol Ventures LLC

 
United States

Hansoh Pharma

 
United Kingdom

Harness Therapeutics

 
 
United States

Hatteras Venture Partners

 
Canada

HDAX Therapeutics

 
 
United States

Healis Therapeutics, Inc

 
 
United States

Healium

 
Belgium

Health Campus Limburg DC

 
 
United States

Health Innovation Capital

 
 
United States

Healthcare Angels

 
United States

HealthQuest Esoterics, Inc.

 
 
United States

Healthtech Capital

 
United Kingdom

Healx

 
 
United States

HEDA Ventures

 
 
United States

Helicase Ventures

 
China

Hemay Pharma

 
United States

Hemogenyx Pharmaceuticals

 
United States

Henlius

 
 
Finland

Herantis Pharma plc

 
 
United States

Hercules Capital

 
 
Singapore

Heritas Capital Management Pte Ltd

 
 
Monaco

Hestia Investments Ltd.

 
 
United States

Hevolution

 
United States

HHS/ASPR

 
 
United States

Hibiscus Bioventures

 
 
United States

HighCape Capital

 
United States

Hike Ventures

 
 
China

Hillhouse Investment

 
Japan

HILO, Co. Ltd.

 
United States

Hinova Pharmaceuticals Inc.

 
China

HitGen Inc.

 
 
China

HJ Partners

 
 
United States

HM Venture Partners

 
Denmark

Hoba Therapeutics

 
United States

Hogan Lovells US LLP

 
 
United States

Hongjing Capital

 
 
United States

Horizon Technology Finance Management LLC

 
United States

How to Launch an Industry

 
 
Italy

HTH S.r.l.

 
Canada

HTuO Biosciences

 
United States

HuidaGene Therapeutics

 
China

HUITAI Biomedicine

 
United States

Human Longevity

 
United Kingdom

HungaroTrial CRO

 
 
United States

Hunniwell Lake Ventures

 
 
United States

Hyperion Therapeutics, Inc.

 
 
United States

IAG Capital Partners

 
Italy

IAMA Therapeutics

 
United States

IAPP Media

 
 
United States

Iaso Ventures

 
 
United States

ICG PLC

 
South Korea

ICM

 
 
Singapore

ICM limited

 
United States

ICON plc

 
 
China

IDG capital

 
 
United States

IGC - Innovative Growth Capital Health and Wellness Fund LLC

 
 
United States

IGC Pharma Inc.

 
Germany

IGES Institut GmbH

 
 
Singapore

iGlobe Partners

 
 
United States

Ignite Social Impact

 
France

IKTOS

 
 
United States

Illumina Ventures

 
 
United States

Imagion Biosystems

 
United States

Imbrium Therapeutics

 
United States

Immetas Therapeutics

 
 
Netherlands

Immoon Therapeutics

 
Canada

Immugenia Inc.

 
 
China

ImmuneOnco Biopharmaceuticals Inc.

 
United States

Immunexpress

 
 
United States

Immunis, Inc.

 
Canada

ImmunoBiochem

 
United States

Immunophotonics, Inc.

 
United Kingdom

ImmuPharma PLC

 
United States

Immuto Scientific

 
 
United States

Impact India Investment Partners LLC (3iPartners)

 
United States

IMPULSE

 
United States

Imugene

 
 
United States

Imvax, Inc.

 
South Korea

iN Therapeutics

 
Canada

In Vivo

 
 
United States

IN8bio

 
 
China

INCE Capital

 
United States

Inceptor Bio

 
 
United States

InCube Ventures

 
 
Italy

Indaco Bio Fund

 
United States

Indaptus Therapeutics

 
United States

Indegene

 
 
United States

Individual Investor

 
United States

InduPro

 
United States

InduPro Therapeutics

 
United States

Indus Tech Reports

 
 
Sweden

Industrifonden

 
United Kingdom

Infex Therapeutics

 
 
United States

Infinimmune

 
Germany

InflaRx N.V.

 
United Kingdom

Informa Markets

 
 
United States

Inhalon Biopharma

 
United States

Inizio

 
United States

InnDura Therapeutics Inc

 
 
United States

InnoCom Bio Equities, Inc.`

 
United States

Innoland Biosciences

 
 
Switzerland

InnoMedica

 
Austria

Innophore GmbH

 
 
China

InnoPinnacle Fund

 
United States

Innorna

 
 
United States

Innospark Ventures

 
United States

Innov8med.com

 
Japan

Innovacell K.K.

 
 
United States

Innovating Capital

 
 
United States

Innovation Works

 
United States

Innovo Therapeutics

 
 
United States

InnovoTEX Inc.

 
 
Germany

INOGROUP

 
United States

Inomagen Therapeutics

 
 
United States

inovation ventures

 
France

Inpart

 
United Kingdom

InPeak

 
 
United States

Insight Partners

 
Canada

Insilico Medicine

 
United States

Insmed

 
Canada

Integarted Nanotherapeutics

 
Canada

Interaxon Inc. (Muse)

 
United States

Interlaken Associates

 
United States

Intervalent

 
United Kingdom

Intract Pharma

 
United States

Intralink Group

 
United States

Intrommune Therapeutics

 
South Korea

Inventage Lab

 
 
Canada

Invest Ontario

 
Canada

Investing News Network

 
 
Canada

Investissement Quebec

 
China

InxMed

 
 
United States

iO lifeventures

 
China

IONAnalytics Group

 
 
United States

IowaIBO, Inc

 
 
Switzerland

IPF Partners

 
Canada

iProgen Biotech Inc.

 
United States

Ipsen

 
United States

iQure Pharma Inc

 
 
United States

Iron Path Capital, L.P.

 
Canada

Iseehear Inc.

 
Australia

Island Pharmaceuticals

 
 
United Kingdom

IsomAb Ltd

 
 
United States

Isometry Advisors, Inc.

 
 
Italy

Italian Angels

 
 
Taiwan, China

ITIC

 
 
United States

iTolerance, Inc.

 
Canada

ITR Laboratories Canada Inc.

 
Germany

J Lab Med

 
Japan

J -Pharma Co.,Ltd.

 
 
United States

J.P. Morgan, Commercial Bank, Life Sciences

 
 
United States

Jaguar Health, Inc.

 
 
India

Jaia Tech ventures (JT Ventures)

 
 
United States

JDRF T1D Fund

 
 
Switzerland

Jeito Capital

 
 
United States

Jene Advisors

 
United States

Jenno Co.

 
 
United Kingdom

JJDC

 
 
United States

JLS Fund

 
 
United States

JMP Securities

 
Canada

JN Nova Pharmaceuticals

 
United States

Johns Hopkins Bloomberg School of Public Health

 
United States

Johnson & Johnson Innovation

 
 
United States

JonesTrading Institutional Services LLC

 
 
United States

Joy Ventures

 
 
United States

Joyance Partners

 
 
United States

JP Morgan Asset Management Life Sciences Private Capital

 
Japan

JT Pharma

 
United States

Jubilant Biosys Ltd

 
Netherlands

Julius Clinical Research B.V.

 
 
Singapore

Jungle ventures

 
United States

JURA Bio, Inc.

 
United States

Juvena Therapeutics

 
 
United States

K2 HealthVentures

 
 
United States

Kaleida Capital

 
United States

KaloCyte, Inc.

 
United States

KalVista Pharmaceuticals, Inc.

 
 
United States

Kamau Therapuetics, Inc.

 
 
Canada

Kapoose Creek Bio

 
 
Sweden

Karolinska Development

 
 
South Korea

KB Investment

 
 
United States

KCap Biotechnology Fund LP

 
United States

KeifeRx

 
 
United States

Keiretsu Forum

 
 
United States

Kendall Capital Partners Management LLC

 
United Kingdom

Kerna Ventures

 
 
United States

Kernal Biologics

 
 
United States

Kernel

 
 
United States

KESA Partners Inc

 
Norway

Kevad Bio

 
 
United States

Keylika Inc.

 
United States

Keystone Bio, Inc.

 
 
United States

Khosla Ventures

 
 
United States

Kibur Medical Inc.

 
 
United States

Kicker Ventures

 
 
Belgium

Kiji Therapeutics

 
France

Kinathera

 
United States

Kincell Bio

 
 
United States

Kineo Finance

 
United States

Kinexum

 
 
United States

Kingsford Capital Management

 
Canada

Kingston Economic Development

 
United States

KKH Advisors

 
 
United States

Knoubis Bio, Inc

 
United States

KO Law Firm

 
 
United States

Koi Biotherapeutics Inc

 
United States

Koneksa

 
South Korea

Korea Biomedical Review

 
South Korea

Korea Health Industry Development Institute

 
 
United States

Korea Investment Partners

 
South Korea

Korea JoongAng Daily

 
 
United States

Kortuc

 
United States

KOTRA

 
United States

Kowa Pharma Development Company

 
United States

KPS Life

 
United States

KR Scientific Affiars

 
Canada

KreaMedica Inc.

 
United Kingdom

Kuano

 
 
France

Kurma Partners SA

 
United States

Kygent Therapeutics

 
United States

Kymanox

 
United Kingdom

Kynos Therapeutics Ltd.

 
Japan

Kyorin Pharmaceutical Co., Ltd.

 
 
United States

Kyto Technology and Life Sciences

 
 
United States

Kytotech and US ANGELS

 
 
South Korea

L&J Bio,Co.,Ltd.

 
United States

Labcorp

 
 
United States

LabyRx Immuno -Oncology and Sierra College

 
 
United States

Lactiga

 
United States

Lactocore Inc.

 
 
United States

Ladenburg Thalmann

 
United States

Laekna Therapeutics

 
 
United States

Laguna Biotherapeutics, Inc.

 
Netherlands

Laigo Bio

 
United States

LambdaVision

 
 
United States

Landmark Angels/Family Office

 
United States

Lassogen, Inc.

 
United States

Latham BioPharm Group, part of Sia Partners

 
United States

LaVoieHealthScience

 
United States

Law360

 
 
United States

LeaderMed Group Limited

 
United States

Leapfrog Bio

 
United States

Leerink Partners

 
United States

LegoChem Biosciences

 
 
United States

LemVega Capital

 
United States

Leverna Therapeutics

 
Israel

Levicure Ltd

 
United States

Levolta Pharmaceuticals

 
 
United States

Lexi Ventures

 
Netherlands

Liberi Group

 
 
United States

Life Science Angels

 
United States

Life Science Connect

 
United States

Life Science Connect / Life Science Leader

 
Canada

Life Sciences BC

 
 
Spain

LifeLink Ventures

 
United States

LifeSci Partners

 
 
United States

Lifespan Vision Ventures, LLC

 
 
United States

LifeX Ventures

 
 
United Kingdom

LIfT BioSciences

 
 
United States

Lightbank

 
 
China

Lilly Asia Ventures

 
 
United Kingdom

Limerston Capital Partners

 
 
United States

Lincoln Park Capital LLC

 
United States

Lineus Medical

 
China

Lingmed Limited

 
United States

Linnaeus Therapeutics

 
United States

LIPELLA PHARMACEUTICALS INC.

 
United States

Lipidio Pharmaeuticals

 
 
United States

Lipocine Inc.

 
 
Australia

Loftus Peak

 
 
United States

Long State Investments

 
 
Latvia

LongeVC

 
 
United States

Longview Innovation

 
United States

Lonza

 
Denmark

Lophora

 
United States

Lowenstein Sandler LLP

 
 
China

Loyal Valley Capital

 
 
China

LRI

 
 
United States

LSA

 
China

LSCCB

 
 
United Kingdom

LSV Capital Partners

 
United States

LTZ Therapeutics Inc

 
Canada

LUCID Therapeutics

 
United States

Lumanity

 
United States

Lume Health

 
 
Canada

Lumira Ventures

 
United States

Lupin Inc

 
 
United States

lyfe capital

 
 
United States

Lymo Ventures LP

 
 
China

Lynk Pharmaceuticals Co., Ltd.

 
 
China

Lynx Financial Hong Kong Ltd.

 
South Korea

LyseNTech

 
 
China

LYZZ Capital

 
Japan

M Bio Technology Inc./Presiden

 
 
Germany

M Ventures

 
 
China

Mabwell(Shanghai) Bioscience Co., Ltd.

 
Australia

Macquarie University

 
Australia

Macuject Pty Ltd

 
 
United States

Macula Vision Systems

 
 
United States

MAIA BIOTECHNOLOGY INC

 
United States

MaidStone Life Sciences

 
Canada

Mannin Research Inc.

 
United States

MantleBio

 
 
United States

Marathon Asset Management

 
 
United States

March of Dimes

 
United States

Margaretta Colangelo Ventures

 
Austria

Marinomed Biotech AG

 
United States

Marker Therapeutics

 
Japan

Maruho

 
United States

Maryland Department of Commerce

 
United States

MassBio

 
United States

Matica Biotechnology Inc.

 
United States

Matinas BioPharma

 
Netherlands

Matisse Pharmaceuticals B.V.

 
 
China

Matrix Partners China

 
United States

MAXONA Pharmaceuticals, Inc.

 
 
United States

Mayewell Capital

 
 
United States

mayfair capital partners LLC

 
 
United States

Mayo Clinic Ventures

 
United States

MC Services

 
 
United States

McGeever Family Office

 
United States

MD Anderson Cancer Center

 
 
United States

MDB Capital Holdings

 
 
China

Med -Fine Capital

 
 
United States

MedExplore Ventures

 
 
South Korea

MEDI&GENE

 
United States

Media MCC

 
 
United States

Medical Excellence Capital

 
 
Japan

Medical Incubator Japan

 
United States

Medical Technology Stock Letter

 
United States

Medicine to Market

 
United States

Medicus Pharma Ltd.

 
Japan

Medilabo, Inc.

 
Canada

Mediphage Bioceuticals, Inc.

 
 
Singapore

MediSix Therapeutics

 
United States

Medistrava

 
 
United States

Medium Biosciences

 
 
United States

MedTech Advantage Fund

 
 
China

Medtronic China Fund

 
United States

MedWorld Advisors

 
 
United States

MEKanistic Therapeutics, Inc.

 
 
United Kingdom

Meltwind

 
 
South Korea

Mepsgen

 
United States

Merck

 
Singapore

Merck KGaA, Darmstadt, Germany

 
 
United States

Mercury Bio

 
United States

Mergermarket - ION Group

 
 
United States

Meritage Venture Group

 
 
United States

Merlin Biotech, Inc.

 
 
United States

Mesa Verde Venture Partners

 
 
United States

Mesoblast

 
 
United States

Metabolytic Research

 
Japan

Metcela Inc.

 
 
United States

Methuselah Fund

 
 
Switzerland

MetrioPharm AG

 
 
United States

Meyers Investments Family LP

 
United Kingdom

MGB Biopharma Limited

 
United States

MICHBIO

 
 
United States

Michigan Capital Network

 
United Kingdom

Microplate Dx Ltd

 
 
United States

Mid Atlantic Bio Angels

 
 
United States

Midori Management / Personal Investments

 
United States

Milk Care Co., Inc.

 
 
United States

Milky Way Investments

 
 
United States

MindImmune Therapeutics, Inc.

 
Germany

Mindpeak GmbH

 
 
United Kingdom

MindRank Ltd

 
 
United States

Minotaur Therapeutics

 
 
Japan

MiraBiologics Inc.

 
South Korea

MIRACURE

 
United States

Mirador Global LP

 
 
South Korea

Mirae Asset Capital

 
 
United States

Mirimus Inc

 
 
United States

Mirror Biologics, Inc

 
 
United States

Mission BioCapital

 
 
United States

MIT Alumni Angels

 
United States

Mito Pop

 
 
United Kingdom

MitoRx Therapeutics Limited

 
Luxembourg

Mitotech

 
United States

Mitotherapeutix LLC

 
 
United States

Mitsubishi Corporation (Americas)

 
United States

Mitsubishi Tanabe Pharma

 
 
United States

Mitsui Global Investment

 
 
United States

Mitsui&Co.(U.S.A.), Inc.

 
 
Japan

Miyabi Ventures Co., Ltd.

 
 
United States

Mizuho

 
United States

MM +M

 
 
United States

Mobius Scientific Inc.

 
United States

Modality.AI, Inc.

 
 
United States

Modi Venture Capital Management LLC

 
 
United States

Modifi Bio

 
United States

Modulus Therapeutics, Inc.

 
 
Japan

MOLCURE Inc.

 
United States

Molecular Inernational

 
 
United States

Molecular Targeting Technologies, Inc

 
 
Canada

Molecular You

 
 
United Kingdom

Momentum Biotech

 
 
Australia

Monash Innovation

 
Belgium

Montis Biosciences

 
 
United States

Montrose Capital Partners

 
United Kingdom

Monument Tx

 
United States

Moonwalk Biosciences

 
United States

MorepenBio

 
United Kingdom

Morgan Prestwich

 
 
United States

Morgens, Waterfall, Vintiadis & Company, Inc.

 
 
United States

MP Healthcare Venture Management

 
 
New Zealand

MQB Partners Limited

 
 
United States

MRL Ventures Fund

 
Belgium

MRM Health

 
 
United States

Multimeric Biotherapeutics, Inc.

 
United Kingdom

MultiOmic Health

 
Belgium

myNEO Therapeutics

 
 
Denmark

MyoPax Denmark ApS

 
 
Canada

NACO Canada

 
 
United States

Nandi Life Sciences

 
Israel

NANO24

 
Israel

Nanocarry

 
United Kingdom

Nanograb

 
United States

NanoMood

 
United States

NaNotics

 
 
United States

NanoViricides, Inc.

 
 
United States

Narwhal Bio Inc.

 
 
United States

Nassau Street Ventures

 
United States

National Institute of Health -National Institute on Aging

 
United States

National Institutes of Health - SEED

 
United States

National Newspapers Publishers Association

 
United States

Navega Therapeutics

 
Germany

Navigo Proteins GmbH

 
United States

NAYA Biosciences

 
Japan

NB Health Laboratory Co. Ltd.

 
 
Germany

NEC Bio Therapeutics GmbH

 
Turkey

Neo Auvra

 
 
South Korea

NEORNAT incorporation

 
United Kingdom

NeRRe Therapeutics

 
 
United States

Nervonik Inc.

 
 
United States

Nest Catalyst

 
 
United States

Neuro3 Therapeutics, Inc.

 
United States

NeuroBo Pharmaceuticals Inc.

 
United Kingdom

Neurocentrx

 
United States

NeuroCores, Inc

 
 
United States

NeuroGeneces

 
 
United Kingdom

Neurone Services

 
United States

NeuroPerspective

 
United States

NeuroPn Therapeutics, LLC

 
United States

Neurotech Reports

 
 
United States

NeuroTrauma Sciences

 
 
United States

NEVA SGR

 
 
United States

New England Hemolytics, Inc.

 
 
United States

New Enterprise Associates

 
 
United Kingdom

New Medicine Partners

 
United States

New Perspectives, Inc

 
 
United States

New Rhein Healthcare Investors

 
 
United Kingdom

New Science Fund LLC

 
 
United States

New York Fortune Corp

 
South Korea

NEWSIS

 
 
United States

Nex Cubed

 
Norway

Nextera AS

 
South Korea

Nextgen Bioscience

 
United States

NextRNA Therapeutics

 
United States

NextStep Robotics

 
France

NFL Biosciences

 
United States

NGGT Inc.

 
 
United States

NHH Ventures GP, Ltd.

 
China

Nhwa Pharmaceutical

 
United States

NIA/NIH

 
United States

Niconox LLC

 
 
United States

Nieuw Amsterdam Advisors

 
United States

Nitto Innovations, Inc.

 
 
United States

NKILT Therapeutics, Inc.

 
United States

No Patient Left Behind

 
Canada

Noa Therapeutics

 
United States

Nobias Therapeutics

 
 
United States

Noble Capital Markets

 
 
United States

Nodenza Inc

 
 
Switzerland

Nodes Advisors AG

 
United States

Noetik

 
 
United States

Northlea Partners LLLP

 
 
United States

Norwest Venture Partners

 
 
Belgium

Noshaq

 
United States

Nosis Bio

 
France

Nova

 
Switzerland

Novago Therapeutics

 
 
Belgium

Novalis VC Fund

 
 
United States

NovaQuest Capital Management, LLC.

 
United States

NovaRock Biotheraputics

 
 
Canada

Novateur Ventures Inc.

 
 
United States

Novatio Ventures

 
 
Canada

Novel Biotechnology Inc.

 
United States

Novel Microdevices, Inc.

 
South Korea

Novelty Nobility Inc.

 
 
Denmark

Novo Holdings

 
United States

Novo Nordisk A/S

 
Australia

Novotech

 
United States

NS Pharma

 
 
United States

NSIP LLC

 
 
United Kingdom

Nuclera

 
Australia

Nucleus Network

 
Canada

Nucro -Technics

 
 
United States

NuevaBio LLC

 
 
United States

NuFund Venture Group

 
United States

Nuritas

 
United States

NurrOn Pharmaceuticals, INC

 
United Kingdom

NW PharmaTech

 
 
United States

NYBC Ventures

 
United States

NYCEDC

 
 
United States

NYU Stern

 
 
United Kingdom

o2h Ventures LTD

 
Canada

OBIO

 
 
United States

Oceaniq Capital

 
United Kingdom

Ochre Bio

 
United States

OCMS Bio

 
Germany

OCT Clinical GmbH

 
United States

Octane Bio, LLC

 
United States

Ocugenix

 
 
United States

Ocuphire

 
United States

Ohio Life Sciences

 
United States

Oklahoma State University - NCWR

 
United States

Okomera

 
 
United Kingdom

OKYO Pharma LTD

 
United States

Olfera

 
United States

Olio Labs Inc

 
United States

Olon Ricerca Bioscience, LLC

 
United States

OmniAb Inc.

 
Canada

OmniaBio

 
 
Spain

Omniscope

 
 
United Kingdom

OncoBone Ventures Ltd

 
South Korea

ONCOCROSS Co., Ltd.

 
 
United States

Oncology Impact Partners

 
Austria

OncoOne

 
 
United States

OncoRx Insights

 
Canada

Oncoustics

 
 
United States

OniX Hub and Ventures

 
United States

Only Orphans Cote LLC

 
United States

Ono Pharma USA., Inc

 
 
Canada

Ontario Brain Institute

 
Canada

Ontario Government

 
Italy

Opis Research

 
United States

Oppenheimer & Co. Inc.

 
United Kingdom

Oppilotech Ltd

 
United States

Opus Biotech Communications

 
 
United States

Opus8, Inc.

 
 
Australia

Oracle Investment Management

 
United States

Oracle Life Sciences

 
 
United States

Orange Grove Bio

 
 
United States

OrbiMed Advisors LLC

 
United Kingdom

Orbit Discovery Ltd

 
 
United States

Orbits Oncology

 
 
United States

Ordaos

 
 
United States

Oregon Venture Fund

 
 
United States

Oresund Capital

 
United States

Origami Therapeutics, Inc.

 
Germany

Origenis

 
Switzerland

Orio Therapeutics

 
Canada

Orion Biotechnology

 
United States

Orphagen Pharmaceuticals, Inc.

 
 
Spain

Oryzon Genomics, s.a. ESA 62291919

 
Japan

Osaka University

 
 
United States

Osmol Therapeutics, Inc.

 
 
United States

OssiFi Therapeutics

 
 
China

Otovia Therapeutics

 
 
United States

Otsuka -US

 
 
United States

Outset Capital (Outset Capital Fund I, LP)

 
 
United Kingdom

Oxford Cancer Analytics Ltd

 
United Kingdom

Oxford Medical Products Ltd

 
 
United Kingdom

Oxford Science Enterprises

 
United Kingdom

OxSonics Therapeutics

 
 
United States

OYE Therapeutics

 
United States

Pace Life Sciences

 
 
United States

Pacific 8 Ventures

 
 
United States

Pack VC

 
United States

PackGene Biotech

 
Canada

Pacylex Pharmaceuticals, Inc.

 
United States

Palogen, Inc.

 
 
United States

Panacea Venture

 
 
United Kingdom

Panakes Partners SGRSPA

 
 
United States

Pandect Bioventures

 
 
United States

Pangaea Ventures

 
 
United States

Pangen Fund I GP LLC

 
United States

Pano Therapeutics, Inc.

 
 
United States

Papillon Biosciences, Inc.

 
United States

Pappas Capital

 
 
Canada

Paradigm Capital

 
United States

Parexel

 
 
United States

Park Avenue Capital LLC

 
 
United States

Parow Entheobiosciences (ParowBio)

 
Germany

Partex NV

 
 
United States

Particular Ventures

 
United Kingdom

partneringONE

 
United States

Patchwise Labs

 
 
United States

PATH BIOTECH

 
 
United States

Pathway Bioventures

 
 
United States

pattern computer inc

 
Canada

Pattern Pharma

 
 
United States

PC Capital

 
South Korea

Pelemed

 
 
United States

PENG Life Science Ventures

 
 
United States

Pennsylvania Biotechnology Center

 
South Korea

Peptron Inc.

 
Australia

Percheron Therapeutics Limited

 
 
United States

Permanent Capital Management

 
United States

Persista Bio

 
 
United States

Perspective Therapeutics

 
 
United Kingdom

Phaim Pharma

 
 
United States

Phanes Therapeutics, Inc

 
 
United States

Pharma Capital Partners

 
 
United States

PharmaCatalyst

 
United States

Pharmadule Morimatsu AB

 
United States

PharmaLegacy

 
United States

PHARMANEST INC

 
United Kingdom

PharmaVentures Ltd

 
United Kingdom

PharmEnable Therapeutics Limited

 
United States

Pharming Group N.V.

 
United States

PharPoint Research, Inc.

 
 
United States

Phase Two Ventures

 
United Kingdom

Phil Taylor

 
United States

PhotoniCare

 
United Kingdom

Pictura Bio Ltd

 
South Korea

Pin Therapeutics

 
United States

Piton Therapeutics, Inc.

 
 
United States

Pivotal bioVenture Partners

 
 
United States

Pivotal Life Sciences, Inc.

 
 
United States

PKG Health

 
 
United States

Playground Global

 
 
United States

Plum Alley

 
Israel

Pluri Inc

 
United States

Pluto Immunotherapeutics

 
United Kingdom

Pneumagen Ltd

 
 
United States

PoC Capital, LLC

 
United Kingdom

PointLiver Dx

 
United States

Polaris Pharmaceuticals Inc.

 
United States

Polaris Quantum Biotech

 
Poland

Poltreg S.A.

 
Canada

PolyAnalytik Inc

 
United States

Polynoma

 
United States

PolyPeptide

 
United States

POP Biotechnologies, Inc.

 
 
United States

Porfolia Funds

 
 
United States

Portal Innovations

 
 
United States

Praana, Inc.

 
Belgium

Precigen ActoBio

 
Switzerland

PreciHealth

 
 
United States

PrecisioBiotix

 
United States

Precision for Medicine

 
United Kingdom

PrecisionLife

 
 
United States

Predictive Oncology Inc.

 
 
United States

PredxBio, Inc.

 
United States

Premas Technologies Inc.

 
United States

Premier Consulting

 
 
United States

Prevail Partners LLC

 
 
United States

Primarius Capital

 
 
Hungary

Prime Biotech Invetment

 
 
China

Prime Life Science Co., Ltd

 
 
United States

Prime Movers Lab

 
 
United States

Primer Ventures

 
United Kingdom

PrimeVigilance

 
United States

Privo Technologies

 
 
United States

Privos Capital

 
United States

Processa Pharmaceuticals, Inc.

 
Germany

PROFIL IfS GmbH

 
 
United States

Profound Ventures

 
 
United States

Progenicyte Therapeutics, Inc.

 
United States

Project Brighton

 
United States

Prolocor, Inc

 
Canada

Prolucid

 
United States

ProNovo Therapeutics

 
United States

Protagonist Therapeutics

 
Israel

Protai

 
United States

Protibea Therapeutics Inc.

 
 
New Zealand

Provisio Ventures

 
 
United States

Proxima Venture

 
 
United States

PTM Therapeutics, Inc.

 
China

Puhe Biopharma

 
United States

Pullan Consulting

 
Poland

Pure Biologics S.A.

 
 
Singapore

Pureland Global Venture

 
Canada

PurMinds NeuroPharma

 
Japan

PURMX Therapeutics, Inc.

 
 
United States

Purohit Ventures

 
United States

Pylum Biosciences

 
United States

Pyrojas Corporation

 
United States

Pyxis Oncology

 
 
Hong Kong, S.A.R.

Qiming Venture Partners

 
Australia

QIMR Berghofer

 
Canada

Qu Biologics

 
 
China

Quan Capital

 
United States

QuanMol Tech

 
United States

Quantum Media Group, LLC

 
 
United States

Quantum Venture Management Group

 
 
United States

Quince Therapeutics

 
United States

Quotient Sciences

 
Canada

QurCan Therapeutics Inc.

 
United States

R.Tx Capital

 
China

Ractigen Therapeutics

 
 
United States

Radar Therapeutics

 
United States

Radiance Biopharma

 
 
United States

Radiance Therapeutics, Inc.

 
United States

Radiopharm Theranostics

 
 
Ireland

Raglan Capital

 
United States

Rapafusyn Research and Development

 
United States

Ray Therapeutics

 
Canada

Raya Therapeutic, Inc.

 
 
United States

Recode Health Ventures

 
 
Switzerland

Recolony

 
United States

Red Queen Therapeutics

 
United States

Redesign Science

 
 
China

Redhill Capital

 
 
United States

Redrock Family Office

 
 
United States

Redwood Collective

 
 
United States

Reed -Ventures

 
 
United States

RegCell

 
United States

Regeneron Pharmaceuticals, Inc.

 
 
United States

RegFront Technologies

 
 
United States

Reinvigoron Theratech Inc.

 
 
United States

Rejuve.Bio

 
United States

Rejuvenate Bio

 
 
Belgium

Rejuvenate Biomed NV

 
United States

Rejuvenation Technologies

 
Switzerland

Rejuveron

 
 
Canada

Relentless Venture Fund

 
United States

Remedium Bio, Inc

 
 
United States

Remedy Plan Therapeutics

 
 
United States

REMIGES Ventures

 
United States

RenBio

 
 
United States

Renezant, Div. of Earth Science Labs

 
Australia

Resolutum Global

 
United States

Resonac America, Inc.

 
Norway

RESPINOR AS

 
 
United States

Retex Pharmaceuticals Inc

 
United States

ReviveMed Inc.

 
 
Israel

RG&I

 
 
United States

RH Capital

 
 
United States

Riptide Ventures

 
United States

Rise Therapeutics, LLC

 
United States

Riva Therapeutics

 
 
Spain

Riva y Garcia

 
 
United States

Riverine Ventures

 
 
United States

Rivermount VC Fund & Life sciences Angels club

 
 
United States

RiverVest Venture Partners

 
 
United States

RM Global Partners LLC

 
 
Israel

RMGP Biopharma Investment Fund

 
Canada

Rna Diagnostics Inc.

 
 
United States

RND Pharmaceuticals Inc.

 
 
United Kingdom

Rosetta Capital Ltd

 
 
United States

rosewood capital

 
United States

RoslinCT

 
 
United States

RS Oncology LLC

 
 
Canada

RSD Capital Corp

 
 
United States

RT MicroDx

 
 
United States

RTH

 
 
United States

RTW

 
United States

Rubedo Life Sciences

 
 
United States

RUMI Scientific

 
 
United States

Runway Growth Capital

 
United States

Russo Partners

 
 
Germany

RV Invest

 
India

Rx Propellant

 
 
United States

Ryght

 
 
United Kingdom

RYSE Asset Management

 
United States

SAFE pharmaceuticals service co

 
 
Canada

Sagard Healthcare

 
 
United States

Saghmos Therapeutics Inc.

 
 
United States

Saisei Ventures

 
 
United States

Salem Partners

 
Netherlands

Salvia BioElectronics

 
United States

Samsung Biologics

 
 
United States

Samsung Next

 
 
South Korea

Samsung Ventures

 
South Korea

Samyang Holdings Corp.

 
United States

San Francisco Business Times

 
 
United Kingdom

Sana Capital

 
 
United States

Sand Hill Angels

 
 
Canada

Sandman Financial Inc.

 
 
United States

Sangel Capital

 
United Kingdom

Sania Therapeutics

 
 
United States

Sano Chemicals, Inc/

 
United States

Sanofi Ventures

 
 
United States

Santen, Inc.

 
United Kingdom

Sapient Therapeutics

 
 
United States

Sapphiros AiBio

 
United States

Sartorius

 
 
Japan

SBI Investment Co., Ltd.

 
United Kingdom

Scendea Ltd.

 
 
Netherlands

Scenic Biotech

 
 
United Kingdom

Schroders

 
United States

Schrodinger

 
 
United States

SciNeuro Pharmaceuticals

 
 
United States

Scioto Biosciences

 
 
United States

Scotiabank

 
 
United States

SCP Ventures, LLC

 
United States

Scrip

 
United States

SDC

 
 
China

SDIC Fund Co., Ltd.

 
 
United States

SDL Ventures LLC

 
France

SeaBeLife Biotech

 
United States

Seal Rock Therapeutics

 
 
Sweden

Second Swedish Pension Fund (AP2<9

 
 
France

Seed4Soft

 
 
United States

SeedFolio

 
United States

Self/Fast Company

 
United States

Selvita

 
United States

Sen -Jam Pharmaceutical

 
United States

Sengenics Corporation, LLC

 
United States

Senju Pharmaceutical Co.,Ltd.

 
 
United States

SentioDx

 
South Korea

Seoul Economic Daily

 
United States

Seraxis Inc.

 
 
United States

Serent Capital

 
United States

Servier

 
 
South Korea

SevenTree Equity Partners

 
 
United Kingdom

Seventure Partners

 
 
United States

SF Growth Capital

 
United States

SF Writer

 
China

Shanghai Amphiprotech Biomedical Co., Ltd.

 
 
China

Shanghai Healthcare Angel Capital

 
China

Shanghai Henlius Biotech, Inc.

 
United States

Shanton Pharma USA, Inc.

 
South Korea

Shaperon

 
United States

ShareVault

 
Australia

Shaw and Partners

 
 
United States

Shaw Strategic Capital LLC

 
China

Shenzhen TargetRx, Inc.

 
 
China

Sherpa Healthcare Partners

 
South Korea

SHIFTBIO INC.

 
 
Japan

Shinsei Capital Partners, Ltd.

 
Japan

Shionogi & Co., Ltd.

 
 
China

shiyu capital

 
 
United States

Sidereal Therapeutics Inc.

 
United States

Signalexis

 
 
United States

Silicon Valley Bank

 
United States

Silicon Zombies podcast

 
 
United Kingdom

silvermount

 
 
United States

Sinaptica Therapeutics

 
Germany

Sinfonie LSM GmbH

 
United States

Singh Biotechnology

 
United States

Siolta therapeutics

 
 
United States

SIRPant Immunotherapeutics

 
 
United States

SiVEC Biotechnologies, Inc.

 
United Kingdom

Sixfold Bioscience

 
 
United States

Sixth Borough Capital

 
 
United States

Sixth Street Partners

 
 
Canada

Sixty Degree Capital

 
 
China

Sky9 Capital Fund V, L.P.

 
United States

SmartLabs

 
 
United States

Smartlens, Inc.

 
 
South Korea

Smilegate Investment Inc.

 
 
South Korea

SMsino Technology Investment

 
United States

Sofinnova Investments

 
Japan

SONIRE Therapeutics Inc.

 
 
United States

Sontag Foundation

 
 
United States

Sony Corporation

 
 
United States

Sosv

 
 
United States

Sound Bioventures

 
 
China

sourcecode capital

 
 
United States

South Rampart Pharma, Inc.

 
Australia

Southern Star Research Pty Ltd

 
 
United States

Sozo Ventures

 
United States

Spartan Capital

 
United States

Sparx Biotech

 
Canada

Specific Biologics Inc.

 
Canada

Spiderwort Inc

 
United States

SpineThera

 
United Kingdom

Spirea

 
 
United States

SPRIM Global Investments

 
United States

Springer Nature

 
 
United States

SpringRock Ventures

 
 
United States

SQ Innovation, Inc.

 
 
United States

StageNext Ventures

 
United States

Stamm Vegh Corporation

 
South Korea

Standigm

 
United States

Stanford University

 
Israel

Star Tree Ventures

 
 
United States

Starton Therapeutics

 
United States

STAT News

 
 
United States

Stelliger Partners

 
 
United States

Stem Pharm

 
 
United States

Stephens, Inc.

 
 
United States

SternAegis Ventures

 
United States

Stifel

 
United States

Stingray Therapeutics

 
 
United States

Stoc*Doc Partners

 
United States

Stroma Medical

 
 
United States

Sugati Ventures

 
Japan

Sumitomo Pharma

 
 
Hong Kong, S.A.R.

Summer Capital

 
United States

Sun Genomics, Inc.

 
United States

Suntec Medical, Inc.

 
Japan

Surv BioPharma Inc

 
 
United States

SV Investment

 
 
United States

SV Latam Capital

 
United Kingdom

Swarm Oncology

 
Sweden

SwedenBIO

 
United States

Swiss Business Hub USA

 
Switzerland

SWISS ROCKETS AG

 
 
United States

SWK Holdings

 
United Kingdom

Sygnature Discovery

 
 
United States

Symbiotic Capital

 
Sweden

Synartro AB

 
 
Taiwan, China

Syncell Inc.

 
United States

Synchron

 
United States Minor Outlying Islands

Syneos Health

 
United States

Syner -G BioPharma Group

 
 
United States

Synergy Ventures

 
India

Syngene International

 
Denmark

SYNKLINO A/S

 
 
United States

Synlico Inc.

 
 
United States

Syno Capital, LLC

 
United States

Syntekabio Inc.

 
 
United States

Syzygy Therapeutics, LLC

 
 
United States

Tachyon Ventures

 
 
United States

TAE Life Sciences

 
Taiwan, China

TAHO Pharmaceuticals Ltd.

 
 
United States

Taiho Ventures, LLC.

 
Japan

Taisho Pharmaceutical Co., LTD

 
 
Taiwan, China

Taiwania Capital management

 
United Kingdom

Talentmark Ltd

 
France

Tamar Robotics Ltd.

 
 
Saudi Arabia

Tamer Group

 
 
Italy

Tandem Ventures Srl

 
 
United States

Tang Capital LLC

 
Canada

Targa Biomedical

 
 
Australia

Tarnagulla Ventures Pty Ltd

 
United States

TARSUS

 
United States

TAUC3 BIOLOGICS LIMITED

 
United Kingdom

Tay Therapeutics

 
Germany

TCBalance Biopharmaceuticals GmbH

 
 
United States

Team8

 
United States

Technology Holdings

 
 
United States

Technomark Life Sciences

 
United States

Tegmine Therapeutics

 
Japan

Teikoku Seiyaku Co., Ltd.

 
 
United States

Telegraph Hill Partners

 
 
China

Tenry Pharm

 
 
Canada

Teralys Capital

 
United States

Tergus Pharma

 
 
United States

Terrapeutics Pharma

 
 
Australia

Tessara Therapeutics

 
 
China

TF Venture Capital Management Co., Ltd.

 
South Korea

The Asia Business Daily

 
South Korea

The bell

 
South Korea

THE BIO

 
United States

The Bio Report

 
South Korea

The electronic times

 
 
United States

The Forest Road Company

 
 
United States

The Global Emerging Markets Group

 
United States

The Imaging Wire

 
South Korea

The Korea Herald

 
 
United States

The Lind Partners

 
United States

The MedTech Strategist

 
United States

The Money Channel NYC Inc.

 
 
United States

The Norinchukin Bank

 
United States

The San Francisco Standard

 
United States

The Wall Street Journal

 
 
United States

Theradaptive, Inc.

 
France

Theranexus SA

 
Canada

Theratechnologies Inc.

 
 
Canada

TheraVac Biologics

 
 
United States

Thiel Bio

 
United States

Thirona Bio

 
United Kingdom

ThirtyFiveBio

 
United States

Thomas Jefferson University

 
 
Netherlands

Thuja Capital

 
United States

Tiberend Strategic Advisors, Inc.

 
 
United States

TikkunLev Therapeutics

 
United States

TileDB, Inc.

 
Finland

TILT Biotherapeutics Ltd.

 
 
United Kingdom

Tiziana Life Sciences

 
 
United States

TLGY Acquisition Corporation

 
 
United States

Tonic Bioventures, LLC

 
 
United States

Tonix Pharmaceuticals

 
 
United States

Top Harvest Capital

 
 
Switzerland

Topadur Pharma AG

 
Germany

Topas Therapeutics. GmbH

 
India

Topia Lifesciences Limited

 
 
United States

Torrey Pines Investment

 
 
United States

Touchdown Ventures

 
 
United States

TPG Life Sciences Innovations

 
United States

Tranquil Clinical Research

 
 
United States

Translink Capital

 
 
United States

Transpacific Venture Capital Partners

 
Germany

Trials24 GmbH

 
United States

Triangle Insights Group

 
 
China

Triastek, Inc.

 
 
United States

Tribeca Companies

 
Canada

Triera Biosciences Ltd.

 
 
Sweden

Trill Impact Ventures

 
 
United States

Trilo Therapeutics

 
 
United States

Trinity Capital

 
 
Singapore

Trinity Innovation Bioventure Singapore

 
 
United States

Triplebar

 
United States

TRIPP

 
United States

Tryp Therapeutics

 
 
United States

TSVC

 
United States

Tungsten Advisors

 
Hungary

Turbine

 
 
Canada

TVM Capital Life Science

 
 
United States

Two Bear Capital

 
China

TYK Medicines, Inc.

 
United States

Type6 Therapeutics

 
Japan

UBE Corporation

 
 
China

UgeneX Therapeutics

 
 
Israel

UltraSight

 
Sweden

Umecrine Cognition

 
 
United States

UN&UP

 
United States

Unipharm

 
Japan

United Immunity Co., Ltd.

 
United Kingdom

University of Nottingham

 
United States

Univfy Inc.

 
 
United States

Urth Capital Advisors

 
 
United States

UTokyo Innovation Platform Co., Ltd.

 
United States

Uvax Bio, LLC

 
 
Belgium

V -Bio Ventures

 
 
United States

V2M Capital

 
United States

VA Bio

 
 
United Kingdom

VacV Biotherapeutics UK Limited

 
 
United States

Valuence Capital

 
Switzerland

Vandria

 
 
United States

Variant Bio, Inc.

 
 
Japan

VCCT Inc.

 
France

VECT -HORUS

 
 
United States

Vector Capital

 
 
United States

VectorPoint Ventures, LLC

 
United States

Venable LLP

 
Switzerland

Venture Valuation Inc.

 
 
United States

Veradermics

 
 
United States

VerImmune inc

 
Switzerland

Versant Ventures

 
 
Singapore

Vertex Growth Fund

 
United States

Vertex Pharmaceuticals

 
 
Singapore

Vertex Ventures China

 
United States

Vesica Health

 
 
United States

VESTECK, Inc.

 
 
United States

VIAN Therapeutics

 
United States

Vicardia

 
 
Singapore

Vickers Venture Partners

 
 
United States

Vida Ventures

 
United States

ViewMind Inc.

 
 
United States

Vine Ventures

 
 
United States

VintaBio

 
 
United States

Virginia Venture Partners

 
United States

VIrogen Biotechnology Inc.

 
United Kingdom

Virothera Ltd

 
United States

Virtici LLC

 
United States

Viscera Labs, Inc.

 
United States

Visible Alpha

 
 
Mexico

Vision Ventures

 
 
United States

Vista Capital Advisors, LLC

 
 
Canada

Vistara Growth

 
United States

Vita Therapeutics

 
United States

Vitamin Z

 
 
United States

Viva BioInnovator

 
 
China

Viva Biotech

 
 
United States

Vivo Capital

 
United States

Vivodyne

 
Canada

VJO CANADA INC.

 
 
United States

Vocxi Health

 
South Korea

VSPharmTech

 
Ireland

Vzarii Therapeutics

 
United States

Wallonia Export & Investment Agency (AWEX)

 
 
United States

WARF Ventures

 
 
United States

Watershed Therapeutics

 
United States

Wayfinder Biosciences

 
United States

WBB Securities

 
 
China

Westlake Genetech

 
 
Netherlands

Whale Bay Capital

 
 
United States

Whiz Partners

 
 
Japan

Whiz Partners, Inc.

 
United States

WideTrial, Inc.

 
 
United States

William Galle & Associates

 
United States

Wilson Sonsini

 
 
United States

Windham Ventures

 
United States

WIRED

 
 
United States

Wisemont Capital

 
 
United States

WMCS Investments

 
 
Germany

WMT AG

 
 
China

WONDFO BIOTECH

 
 
United States

WRF Capital

 
United States

WTWH Media LLC

 
China

Wuhan YZY Biopharma Co., Ltd.

 
United States

WuXi AppTec

 
 
United States

WuXi Biologics Healthcare Venture

 
Switzerland

Wyss Center

 
 
United States

Xcellerant Ventures

 
 
China

Xiling Lab

 
 
Taiwan, China

XinChen Investment, Inc.

 
United States

XOMA

 
 
United States

Xontogeny

 
United States

Xosomix

 
 
Belgium

Xpand Partners

 
United States

XtalPi Inc

 
 
United States

Xylyx Bio, Inc.

 
 
China

YAFO Capital (Shanghai)

 
United Kingdom

Yakumed Limited

 
 
United States

Yangtze Investment BVI

 
United States

YDS Pharmatech

 
 
China

Yijing Capital

 
 
China

Yoltech Therapeutics Co., Ltd

 
South Korea

Yonhap News Agency

 
 
United States

Yonjin Venture

 
 
United States

Yorkville Advisors Global, LP

 
United States

YourChoice Therapeutics

 
South Korea

Yuhan Corporation

 
 
China

Yunion Healthcare Ventures

 
 
China

Yunquan Biological Technology (Beijing) Co., Ltd

 
United States

Zafrens

 
 
United States

Zauber Ventures

 
United States

Zehna Therapeutics

 
United States

ZEISS Microscopy

 
Canada

Zenith Epigenetics Ltd.

 
 
United States

Zenon Biotech

 
 
United States

Zentynel Frontier Investment

 
United States

Zeon Ventures

 
China

ZHONGMOU Medical TechnologyWuhanCo.,Ltd

 
Canada

Zilia

 
United States

Zimmons International

 
 
Australia

ZiP Diagnostics Pty Ltd

 
United States

ZWI Therapeutics

 
South Korea

Zymedi

 
Canada

Zymeworks

 
 
United States

ZyNext Ventures

 
 
United States

Zyvran Pharmaceuticals